Global Information
회사소개 | 문의 | 비교리스트

세계의 자동 및 폐쇄형 세포 조정 시스템 시장 규모, 점유율, 동향 분석 : 워크플로우별(분리, 확장), 유형별(비줄기세포, 줄기세포), 규모별 예측(2021-2028년)

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Non-stem Cell, Stem Cell), By Scale, And Segment Forecasts, 2021 - 2028

리서치사 Grand View Research, Inc.
발행일 2021년 11월 상품 코드 1036653
페이지 정보 영문 136 Pages
가격
US $ 5,950 ₩ 7,232,000 Unprintable PDF (Single User License)
US $ 6,950 ₩ 8,448,000 Printable PDF (5-User License)
US $ 8,950 ₩ 10,879,000 Printable PDF (Enterprise License)


세계의 자동 및 폐쇄형 세포 조정 시스템 시장 규모, 점유율, 동향 분석 : 워크플로우별(분리, 확장), 유형별(비줄기세포, 줄기세포), 규모별 예측(2021-2028년) Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion), By Type (Non-stem Cell, Stem Cell), By Scale, And Segment Forecasts, 2021 - 2028
발행일 : 2021년 11월 페이지 정보 : 영문 136 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 자동·폐쇄형 세포 조정 시스템 시장 규모는 예측 기간 중 21.7%의 CAGR로 확대하며, 2028년까지 29억 4,000만 달러에 달할 것으로 예상되고 있습니다.

시장 관계자는 세포치료 제품의 개발 프로세스를 가속시키기 위한 전략으로서 자동화 프로세스 시스템의 도입에 거액의 투자를 시행하고 있으며, 이것이 시장 성장의 원동력이 되고 있습니다.

GMP 제조 시설의 확대는 상업 활동에서 자동화 프로세스의 도입을 한층 더 지원하고 있습니다. 또한 일회용 튜브 세트 및 백은 응용 범위가 넓으므로 치료 연구개발의 자동화가 촉진됩니다. 또한 주요 기업은 제조 랩에 자동화 기술을 효과적으로 도입하기 위한 전략을 세우고 있으며, 이것이 매출의 확대로 연결되고 있습니다.

세계의 자동·폐쇄형 세포 조정 시스템 시장에 대해 조사분석했으며, 시장 및 업계 전망, 부문별·지역별 시장 전망 및 경쟁 구도에 관한 정보를 정리하여 전해드립니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향, 범위

  • 시장 세분화

제4장 업계의 전망

  • 모시장 계통
  • 보조적인 시장 계통
  • 시장 역학
    • 시장 성장요인 분석
    • 시장 억제요인 분석
    • 시장의 기회 분석
    • 시장이 해결해야 할 과제 분석
  • SWOT 분석;요인별(정치적 및 법적, 경제적 및 기술적)
  • Porter의 산업 분석
  • 주요 거래와 전략적 제휴 분석
    • 합병·인수
    • 기술 협력과 파트너십
    • 제품 승인과 발매
  • Covid-19의 영향 분석
    • 과제 분석
    • 시장 기회 분석
    • 주요 동향과 활동

제5장 경쟁 분석

  • 기업의 지도제작
  • 잠재적 최종사용자 리스트
  • 신규 기업 리스트
  • 시장 차별화 요인
  • 경쟁 대시보드 분석
  • 지역 네트워크 맵

제6장 워크플로우별 시장 분석

  • 자동·폐쇄형 세포 조정 시스템 시장 : 워크플로우별 시장의 동향 분석
  • 분리
  • 확장
  • 아페레시스
  • Fill-Finish
  • 동결 보존
  • 기타

제7장 유형별 시장 분석

  • 자동·폐쇄형 세포 조정 시스템 시장 : 유형별 시장의 동향 분석
  • 줄기세포 치료
  • 비줄기세포 치료

제8장 규모별 시장 분석

  • 자동·폐쇄형 세포 조정 시스템 시장 : 규모별 시장의 동향 분석
  • 프리커머셜/R&D 규모 제조
  • 상업 규모 제조

제9장 지역별 시장 분석

  • 자동·폐쇄형 세포 조정 시스템 시장 : 지역별 시장의 동향 분석
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제10장 기업 개요

  • 전략 프레임워크
  • 시장 참여 분류
  • 기업 개요
KSA 21.11.29

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of automated and closed cell therapy processing systems manufacturers
  • Table 3 List of potential end-users
  • Table 4 List of emerging players
  • Table 5 List of market differentiators
  • Table 6 Competitive dashboard analysis
  • Table 7 Regional network map
  • Table 8 North America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 9 North America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 10 North America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 11 U.S. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 12 U.S. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 13 U.S. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 14 Canada automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 15 Canada automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 16 Canada automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 17 Europe automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 18 Europe automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 19 Europe automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 20 Germany automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 21 Germany automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 22 Germany automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 23 U.K. automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 24 U.K. automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 25 U.K. automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 26 Italy automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 27 Italy automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 28 Italy automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 29 Spain automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 30 Spain automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 31 Spain automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 32 France automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 33 France automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 34 France America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 35 Asia Pacific automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 36 Asia Pacific automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 37 Asia Pacific automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 38 China automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 39 China automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 40 China automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 41 Japan automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 42 Japan automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 43 Japan automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 44 India automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 45 India automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 46 India automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 47 South Korea automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 48 South Korea automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 49 South Korea automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 50 Australia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 51 Australia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 52 Australia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 53 Latin America automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 54 Latin America automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 55 Latin America automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 56 Brazil automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 57 Brazil automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 58 Brazil automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 59 Mexico automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 60 Mexico automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 61 Mexico automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 62 MEA automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 63 MEA automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 64 MEA automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 65 South Africa automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 66 South Africa automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 67 South Africa automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 68 Saudi Arabia automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 69 Saudi Arabia automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 70 Saudi Arabia automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)
  • Table 71 UAE automated and closed cell therapy processing systems, by workflow, 2017 - 2028 (USD Million)
  • Table 72 UAE automated and closed cell therapy processing systems, by type, 2017 - 2028 (USD Million)
  • Table 73 UAE automated and closed cell therapy processing systems, by scale, 2017 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Classification of companies
  • Fig. 9 Automated and closed cell therapy processing systems market snapshot, 2020 (USD Million)
  • Fig. 10 Automated and Closed Cell Therapy Processing System Market segmentation
  • Fig. 11 Market driver impact
  • Fig. 12 Market restraint impact
  • Fig. 13 Automated and closed cell therapy processing systems market SWOT analysis
  • Fig. 14 Automated and closed cell therapy processing systems market Porter's five forces analysis
  • Fig. 15 Automated and closed cell therapy processing systems market : Workflow outlook and key takeaways
  • Fig. 16 Automated and closed cell therapy processing systems market : Workflow movement analysis
  • Fig. 17 Separation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 18 Expansion market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 19 Apheres is market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 20 Fill-Finish market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 21 Cryopreservation market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 22 Others market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 23 Automated and closed cell therapy processing systems market : Type outlook and key takeaways
  • Fig. 24 Automated and closed cell therapy processing systems market : Type movement analysis
  • Fig. 25 Stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 26 Non-stem cell therapy market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 27 Automated and closed cell therapy processing systems market : Scaleoutlook and key takeaways
  • Fig. 28 Automated and closed cell therapy processing systems market : Scale movement analysis
  • Fig. 29 Pre-commercial/ R&D scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 30 Commercial scale manufacturing market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 31 Automated and closed cell therapy processing systems market : Regional outlook and key takeaways
  • Fig. 32 Automated and closed cell therapy processing systems market : Regional movement analysis
  • Fig. 33 North America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 34 U.S. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 35 Canada cell and gene therapy manufacturing) market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 36 Europe automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 37 Germany automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 38 U.K. automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 39 France automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 40 Italy automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 41 Spain automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 42 Asia Pacific automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 43 Japan automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 44 China automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 45 India automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 46 South Korea automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 47 Australia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 48 Latin America automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 49 Brazil automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 50 Mexico automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 51 Middle East & Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 52 South Africa automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 53 Saudi Arabia automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 54 UAE automated and closed cell therapy processing systems market estimates and forecast, 2017 - 2028 (USD Million)
  • Fig. 55 Strategy framework
  • Fig. 56 Market participation categorization

Automated And Closed Cell Therapy Processing Systems Market Growth & Trends:

The global automated and closed cell therapy processing systems market is expected to reach USD 2.94 billion by 2028, registering a CAGR of 21.7% over the forecast period, according to a new report by Grand View Research, Inc. Market players are making significant investments to introduce an automated process system as a viable strategy to accelerate their cell therapy product development process, thereby driving market growth.

The expansion of GMP manufacturing facilities further supports the implementation of automated processes for commercial operations. In addition, the wide application scope of single-use disposable tubing sets and bags also facilitates automated processing of therapy R&D. Moreover, key entities are undertaking strategies for effective implementation of automation technology in manufacturing labs resulting in lucrative revenue growth.

The rapid growth in the cases of COVID-19 is anticipated to play a vital role in the market growth. The pandemic has led to an increased focus on automation technologies. Moreover, the companies emphasized raising funds with an aim to develop advanced therapies and regenerative medicines to fight against COVID-19. Industry players are also concentrating on the development of new therapies, such as stem cell therapy, natural killer cell therapy, exosomes, and others.

Automated And Closed Cell Therapy Processing Systems Market Report Highlights:

  • The cell expansion workflow segment accounted for the maximum revenue share of the global market in 2020. An increasing focus on achieving high output yield has resulted in the high revenue share of the segment
  • The cell separation workflow segment is estimated to register the fastest CAGR during the forecast period due to an increasing number of stem cell therapy R&D programs
  • Automated apheresis and cryopreservation workflow are also expected to register considerable growth rates over the forecast period due to the growing emphasis on preservation and sorting for cell therapies
  • The non-stem cellular therapies segment dominated the market in 2020 and will expand further at a steady CAGR over the forecast period. The success of CAR T therapies is one of the major driving forces of this segment
  • The pre-commercial/R&D scale segment captured the maximum revenue share in 2020 due to the increased number of research and innovation activities for new drug & therapy developments
  • North America emerged as the highest revenue-generating region in 2020 owing to the presence of a large number of approved therapies in the region influencing the market players to invest in more R&D programs
  • Companies are undertaking strategic initiatives, such as partnerships and collaborations, to gain higher market shares. For instance, in January 2021, Fresenius Kabiformed a joint venture with Bio-Techne to launch ScaleReady, to develop a scalable and versatile therapy manufacturing platform

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1. Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.8 Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Competition Milieu
  • 2.2 Segment Outlook
  • 2.3 Market Summary, 2020 (USD Million)

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Industry Outlook

  • 4.1 Parent Market Lineage
  • 4.2 Ancillary Market Lineage
  • 4.3 Market Dynamics
    • 4.3.1 Market driver analysis
      • 4.3.1.1 Rising Emphasis On Regenerative Medicines And Cell Therapies
      • 4.3.1.2 Operational Superiority Of Automated Systems Over Manual Processing
      • 4.3.1.3 Extensively Increasing Technological Advancements
    • 4.3.2 Market Restraint Analysis
      • 4.3.2.1 Biological Variations Associated With Different Therapies
    • 4.3.3 Market opportunity analysis
      • 4.3.3.1 Growing Fund-Raising Activities By Companies For New Technology Development
      • 4.3.3.2 Research Activitis And Product Innovations
    • 4.3.4 Market Challenge Analysis
      • 4.3.4.1 Complicated Process Of Automation
  • 4.4 SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
  • 4.5 Porter's Five Forces Analysis
  • 4.6 Major Deals and Strategic Alliances Analysis
    • 4.6.1 Mergers And Acquisitions
    • 4.6.2 Technological Collaborations And Partnerships
    • 4.6.3 Product Approvals And Launches
  • 4.7 Covid-19 Impact Analysis
    • 4.7.1 Challenge Analysis
    • 4.7.2 Opportunity Analysis
    • 4.7.3 Key Developments And Activities

Chapter 5 Competitive Analysis

  • 5.1 Company Mapping
  • 5.2 List of Potential End Users
  • 5.3 List of Emerging Players
  • 5.4 Market Differentiators
  • 5.5 Competitive Dashboard Analysis
  • 5.6 Regional Network Map

Chapter 6 Workflow Business Analysis

  • 6.1 Automated and Closed Cell Therapy Processing Systems Market: Workflow Movement Analysis
  • 6.2 Separation
    • 6.2.1 Separation Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.3 Expansion
    • 6.3.1 Expansion market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.4 Apheresis
    • 6.4.1 Apheresis market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.5 Fill-Finish
    • 6.5.1 Fill-Finish Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.6 Cryopreservation
    • 6.6.1 Cryopreservation market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 7 Type Business Analysis

  • 7.1 Automated and Closed Cell Therapy Processing Systems Market: Type Movement Analysis
  • 7.2 Stem Cell Therapy
    • 7.2.1 Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 7.3 Non-Stem Cell Therapy
    • 7.3.1 Non-Stem Cell Therapy Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 8 Scale Business Analysis

  • 8.1 Automated and Closed Cell Therapy Processing Systems Market: Scale Movement Analysis
  • 8.2 Pre-Commercial/R&D Scale Manufacturing
    • 8.2.1 Pre-Commercial/R&D Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)
  • 8.3 Commercial Scale Manufacturing
    • 8.3.1 Commercial Scale Manufacturing Market Estimates And Forecast, 2017 - 2028 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Automated and Closed Cell Therapy Processing Systems Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America Automated And Closed Cell Therapy Processing Sysytems Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.2.2.2 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.2.2.3 U.S. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.2.3.2 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.2.3.3 Canada Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.2.2 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.2.3 Germany Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.3.2 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.3.3 U.K. Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.4.2 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.4.3 France Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.5.2 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.5.3 Italy Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.3.6.2 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.3.6.3 Spain Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.4.2 Japan
      • 9.4.2.1 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.2.2 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.2.3 Japan Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.3 China
      • 9.4.3.1 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.3.2 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.3.3 China Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.4.2 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.4.3 India Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.5.2 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.5.3 South Korea Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.4.6 Australia
      • 9.4.6.1 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.4.6.2 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.4.6.3 Australia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America automated And Closed Cell Therapy Processing Systems Market estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.5.2.2 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.5.2.3 Brazil Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.5.3.2 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.5.3.3 Mexico Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
  • 9.6 Middle East & Africa
    • 9.6.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Estimates And Forecast, 2017 - 2028 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.2.2 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.2.3 South Africa Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.3.2 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.3.3 Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)
    • 9.6.4 UAE
      • 9.6.4.1 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Workflow, 2017 - 2028 (USD Million)
      • 9.6.4.2 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Type, 2017 - 2028 (USD Million)
      • 9.6.4.3 UAE Automated And Closed Cell Therapy Processing Systems Market Size & Forecasts And Trend Analysis, By Scale, 2017 - 2028 (USD Million)

Chapter 10 Company Profiles

  • 10.1 Strategy Framework
  • 10.2 Market Participation Categorization
  • 10.3 Company Profiles
    • 10.3.1 MILTENYI BIOTEC
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Product Benchmarking
      • 10.3.1.3 Strategic Initiatives
    • 10.3.2 LONZA
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Financial Performance
      • 10.3.2.3 Product Benchmarking
      • 10.3.2.4 Strategic Initiatives
    • 10.3.3 FRESENIUS KABI
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Financial Performance
      • 10.3.3.3 Product Benchmarking
      • 10.3.3.4 Startegic Initiatives
    • 10.3.4 CYTIVA (DANAHER CORPORATION)
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Financial Performance
      • 10.3.4.3 Product Benchmarking
      • 10.3.4.4 Startegic Initiatives
    • 10.3.5 BIOSPHERIX, LTD.
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Product Benchmarking
      • 10.3.5.3 Startegic Initiatives
    • 10.3.6 TERUMO CORPORATION
      • 10.3.6.1 Company Overview
      • 10.3.6.2 Financial Performance
      • 10.3.6.3 Product Benchmarking
      • 10.3.6.4 Startegic Initiatives
    • 10.3.7 SARTORIUS AG
      • 10.3.7.1 Company Overview
      • 10.3.7.2 Financial Performance
      • 10.3.7.3 Product Benchmarking
      • 10.3.7.4 Startegic Initiatives
    • 10.3.8 THERMOGENESIS HOLDINGS, INC.
      • 10.3.8.1 Company Overview
      • 10.3.8.2 Financial Performance
      • 10.3.8.3 Product Benchmarking
      • 10.3.8.4 Startegic Initiatives
    • 10.3.9 CELLARES INC.
      • 10.3.9.1 Company Overview
      • 10.3.9.2 Product Benchmarking
      • 10.3.9.3 Startegic Initiatives
    • 10.3.10 THERMO FISHER SCIENTIFIC, INC.
      • 10.3.10.1 Company Overview
      • 10.3.10.2 Financial Performance
      • 10.3.10.3 Product Benchmarking
      • 10.3.10.4 Startegic Initiatives
Back to Top
전화 문의
F A Q